Charles River Laboratories (CRL)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 3,461,500 | 3,596,880 | 2,976,290 | 2,534,820 | 2,114,600 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $3,461,500K)
= 0.00
The debt-to-capital ratio for Charles River Laboratories has consistently been 0.00 over the five-year period from December 31, 2020, to December 31, 2024. A debt-to-capital ratio of 0.00 indicates that the company has not utilized any debt in its capital structure during this period. This may suggest that Charles River Laboratories has been funding its operations and growth primarily through equity financing rather than taking on debt. While a low debt-to-capital ratio can signify financial strength and stability, it's important to consider the reasons behind this ratio and assess the overall financial health of the company in conjunction with other financial metrics.
Peer comparison
Dec 31, 2024